-
InnoCare Announces Approval of Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China
Market news
PharmaSources.comMarch 28, 2022
InnoCare Pharmaannounced today that the company has received Investigational New Drug (IND) approval of clinical trial from the NMPA...
-
Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment
Market news
PharmaSources.comMarch 25, 2022
Hitachi, Ltd. (TSE: 6501), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment.
-
Immunogenicity Information in Labeling
Market news
FDAMarch 25, 2022
This webinar has been approved for 1.5 contact hours of continuing education for pharmacists, physicians, and nurses. Please see detailed announcement for additional information.
-
Kingworld Medicines Group Issues Positive Profit Alert for 2021
Market news
PharmaSources.comMarch 24, 2022
Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert as it expects to record...
-
TANAKA Develops Gold Shell Nanoparticles That Can Be Prepared in High Concentrations Using High Dispersion Stability
Market news
PharmaSources.comMarch 24, 2022
Achieving dispersion liquids with high concentrations that are 100 to 1,000 times that of existing products with expected applications in optical devices such as optical displays, optical sensing, and biosensors.
-
Joint Research Shows that DENSO's Microalga, Coccomyxa sp. KJ Has Virucidal Effect against COVID-19
Market news
PharmaSources.comMarch 24, 2022
Chubu University, Tokai University, Tohoku University School of Medicine and DENSO Corporation have found that monogalactosyl diacylglyceride (MGDG), a component contained in the chloroplasts of a microalga...
-
GMP certification for Exothera further extends its viral vector manufacturing capacity
Market news
PharmaSources.comMarch 24, 2022
Exothera S.A., a CDMO specialized in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products...
-
InnoCare Releases 2021 Annual Results and Business Highlights
Market news
InnoCareMarch 23, 2022
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing...
-
Coriolis Pharma and U-Medico Announce a Strategic Alliance
Market news
b3cnewswireMarch 17, 2022
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation...
-
Hua Medicine Announces 2021 Annual Results
Market news
PharmaSources.comMarch 17, 2022
Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period").
InnoCare Pharmaannounced today that the company has received Investigational New Drug (IND) approval of clinical trial from the NMPA...
Hitachi, Ltd. (TSE: 6501), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment.
This webinar has been approved for 1.5 contact hours of continuing education for pharmacists, physicians, and nurses. Please see detailed announcement for additional information.
Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert as it expects to record...
Achieving dispersion liquids with high concentrations that are 100 to 1,000 times that of existing products with expected applications in optical devices such as optical displays, optical sensing, and biosensors.
Chubu University, Tokai University, Tohoku University School of Medicine and DENSO Corporation have found that monogalactosyl diacylglyceride (MGDG), a component contained in the chloroplasts of a microalga...
Exothera S.A., a CDMO specialized in the development and manufacture of viral vectors for vaccines and gene therapies, received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products...
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing...
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation...
Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period").
Pharma Sources Insight JUNE2022
